95 related articles for article (PubMed ID: 26842492)
1. Local Recurrence in the Lateral Lymph Node Compartment: Improved Outcomes with Induction Chemotherapy Combined with Multimodality Treatment.
Kusters M; Bosman SJ; Van Zoggel DM; Nieuwenhuijzen GA; Creemers GJ; Van den Berg HA; Rutten HJ
Ann Surg Oncol; 2016 Jun; 23(6):1883-9. PubMed ID: 26842492
[TBL] [Abstract][Full Text] [Related]
2. Preliminary results of a cohort study of induction chemotherapy-based treatment for locally recurrent rectal cancer.
van Zoggel DMGI; Bosman SJ; Kusters M; Nieuwenhuijzen GAP; Cnossen JS; Creemers GJ; van Lijnschoten G; Rutten HJT
Br J Surg; 2018 Mar; 105(4):447-452. PubMed ID: 29168556
[TBL] [Abstract][Full Text] [Related]
3. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
[TBL] [Abstract][Full Text] [Related]
4. Improved Outcomes for Responders After Treatment with Induction Chemotherapy and Chemo(re)irradiation for Locally Recurrent Rectal Cancer.
Voogt ELK; van Zoggel DMGI; Kusters M; Nieuwenhuijzen GAP; Bloemen JG; Peulen HMU; Creemers GJM; van Lijnschoten G; Nederend J; Roef MJ; Burger JWA; Rutten HJT
Ann Surg Oncol; 2020 Sep; 27(9):3503-3513. PubMed ID: 32193717
[TBL] [Abstract][Full Text] [Related]
5. Clinical outcome of interstitial pulsed dose rate brachytherapy in multimodality treatment of locally advanced primary or recurrent rectal and sigmoid cancer with high risk of incomplete microscopic resection.
Nielsen MB; Rasmussen PC; Tanderup K; Nielsen SK; Fokdal L; Laurberg S; Lindegaard JC
Acta Oncol; 2016 Dec; 55(12):1408-1413. PubMed ID: 27537776
[TBL] [Abstract][Full Text] [Related]
6. CAPIRI-IMRT: a phase II study of concurrent capecitabine and irinotecan with intensity-modulated radiation therapy for the treatment of recurrent rectal cancer.
Cai G; Zhu J; Palmer JD; Xu Y; Hu W; Gu W; Cai S; Zhang Z
Radiat Oncol; 2015 Feb; 10():57. PubMed ID: 25889149
[TBL] [Abstract][Full Text] [Related]
7. Treatment of stage IV gastric cancer with induction chemotherapy using S-1 and cisplatin followed by curative resection in selected patients.
Saito M; Kiyozaki H; Takata O; Suzuki K; Rikiyama T
World J Surg Oncol; 2014 Dec; 12():406. PubMed ID: 25551581
[TBL] [Abstract][Full Text] [Related]
8. Locally recurrent rectal cancer: prognostic factors and long-term outcomes of multimodal therapy.
Pacelli F; Tortorelli AP; Rosa F; Bossola M; Sanchez AM; Papa V; Valentini V; Doglietto GB
Ann Surg Oncol; 2010 Jan; 17(1):152-62. PubMed ID: 19834766
[TBL] [Abstract][Full Text] [Related]
9. Results of a pooled analysis of IOERT containing multimodality treatment for locally recurrent rectal cancer: Results of 565 patients of two major treatment centres.
Holman FA; Bosman SJ; Haddock MG; Gunderson LL; Kusters M; Nieuwenhuijzen GA; van den Berg H; Nelson H; Rutten HJ
Eur J Surg Oncol; 2017 Jan; 43(1):107-117. PubMed ID: 27659000
[TBL] [Abstract][Full Text] [Related]
10. What To Do With Lateral Nodal Disease in Low Locally Advanced Rectal Cancer? A Call for Further Reflection and Research.
Kusters M; Slater A; Muirhead R; Hompes R; Guy RJ; Jones OM; George BD; Lindsey I; Mortensen NJ; Cunningham C
Dis Colon Rectum; 2017 Jun; 60(6):577-585. PubMed ID: 28481851
[TBL] [Abstract][Full Text] [Related]
11. [Treatment and prognostic analysis of ovarian cancer patients with isolated region of lymph node recurrence].
Tu H; Huang H; Huang QD; Li Z; Feng YL; Liu JH
Zhonghua Fu Chan Ke Za Zhi; 2012 Dec; 47(12):928-33. PubMed ID: 23324194
[TBL] [Abstract][Full Text] [Related]
12. Prognostic impact of the lymph node ratio in rectal cancer patients who underwent preoperative chemoradiation.
Kang J; Hur H; Min BS; Lee KY; Kim NK
J Surg Oncol; 2011 Jul; 104(1):53-8. PubMed ID: 21416471
[TBL] [Abstract][Full Text] [Related]
13. Analysis of surgical salvage after failure of primary therapy in rectal cancer: results from Intergroup Study 0114.
Tepper JE; O'Connell M; Hollis D; Niedzwiecki D; Cooke E; Mayer RJ;
J Clin Oncol; 2003 Oct; 21(19):3623-8. PubMed ID: 14512393
[TBL] [Abstract][Full Text] [Related]
14. Transanal Endoscopic Microsurgery (TEM) Following Neoadjuvant Chemoradiation for Rectal Cancer: Outcomes of Salvage Resection for Local Recurrence.
Perez RO; Habr-Gama A; São Julião GP; Proscurshim I; Fernandez LM; de Azevedo RU; Vailati BB; Fernandes FA; Gama-Rodrigues J
Ann Surg Oncol; 2016 Apr; 23(4):1143-8. PubMed ID: 26577119
[TBL] [Abstract][Full Text] [Related]
15. Comparative Outcomes of Neoadjuvant Treatment Prior to Total Mesorectal Excision and Total Mesorectal Excision Alone in Selected Stage II/III Low and Mid Rectal Cancer.
Kulu Y; Tarantino I; Billeter AT; Diener MK; Schmidt T; Büchler MW; Ulrich A
Ann Surg Oncol; 2016 Jan; 23(1):106-13. PubMed ID: 26305025
[TBL] [Abstract][Full Text] [Related]
16. High-dose radiotherapy (60 Gy) with oral UFT/folinic acid and escalating doses of oxaliplatin in patients with non-resectable locally advanced rectal cancer (LARC): a phase I trial.
Vestermark LW; Jensen HA; Pfeiffer P
Acta Oncol; 2012 Mar; 51(3):311-7. PubMed ID: 22248062
[TBL] [Abstract][Full Text] [Related]
17. Tumor response and negative distal resection margins of rectal cancer after hyperthermochemoradiation therapy.
Tsutsumi S; Tabe Y; Fujii T; Yamaguchi S; Suto T; Yajima R; Morita H; Kato T; Shioya M; Saito J; Asao T; Nakano T; Kuwano H
Anticancer Res; 2011 Nov; 31(11):3963-7. PubMed ID: 22110227
[TBL] [Abstract][Full Text] [Related]
18. Neoadjuvant therapy is associated with a reduced lymph node ratio in patients with potentially resectable pancreatic cancer.
Roland CL; Yang AD; Katz MH; Chatterjee D; Wang H; Lin H; Vauthey JN; Pisters PW; Varadhachary GR; Wolff RA; Crane CH; Lee JE; Fleming JB
Ann Surg Oncol; 2015 Apr; 22(4):1168-75. PubMed ID: 25352267
[TBL] [Abstract][Full Text] [Related]
19. R1 rectal resection: look up and don't look down.
Tilly C; Lefèvre JH; Svrcek M; Shields C; Fléjou JF; Tiret E; Parc Y
Ann Surg; 2014 Nov; 260(5):794-9; discussion 799-800. PubMed ID: 25379851
[TBL] [Abstract][Full Text] [Related]
20. Radicality of resection and survival after multimodality treatment is influenced by subsite of locally recurrent rectal cancer.
Kusters M; Dresen RC; Martijn H; Nieuwenhuijzen GA; van de Velde CJ; van den Berg HA; Beets-Tan RG; Rutten HJ
Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1444-9. PubMed ID: 19395199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
